Host-directed antimicrobial peptide biomaterials for combating Gram-negative bacterial infections

Muhammad Adil1,2, Muhammad Arshad1,2, Pengfei Zou1,3

  • 1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Centre for Nanoscience and Technology, Beijing, 100190, China. lill@bit.edu.cn.

Insights

Biomaterial platforms enhance host-defense peptides for treating resistant Gram-negative infections. This approach optimizes peptide efficacy and the immune response, addressing limitations of current therapies.

Area of Science:

  • Biomaterials Science
  • Infectious Diseases
  • Immunology
  • Drug Delivery

Background:

  • Antimicrobial resistance (AMR) is a critical global health crisis, particularly with Gram-negative bacteria like carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae.
  • Conventional antibiotics are often ineffective against these resistant strains due to bacterial defense mechanisms.
  • Alternative therapies like bacteriolytic therapy can cause harmful host immune reactions, while host-defense peptides (HDPs) face challenges in stability and serum protein binding.

Purpose of the Study:

  • To explore the use of biomaterial platforms for designing improved peptide-based therapeutics.
  • To enhance the efficacy of HDPs by controlling their clearance and optimizing the immunological environment.
  • To discuss how biomaterial properties influence macrophage responses and signaling pathways.

Main Methods:

  • Review of existing literature on biomaterial platforms and peptide-based therapeutics for AMR.
  • Discussion of biomaterial characteristics (surface chemistry, mechanical stiffness, protein corona) and their impact on host immune cells, specifically macrophages.
  • Analysis of current limitations in preclinical study endpoints and the need for more clinically relevant models.

Main Results:

  • Biomaterial platforms can increase HDP efficacy by reducing clearance and modulating the immune microenvironment.
  • Macrophage polarization and downstream signaling are significantly influenced by biomaterial properties.
  • Current preclinical evaluation methods (MIC, hemolysis) are insufficient for assessing host-directed effects of these therapies.

Conclusions:

  • Integrating biomaterials engineering with peptide design offers a promising strategy to overcome limitations of current antimicrobial therapies.
  • Future research requires novel endpoints and more relevant animal models to accurately assess the clinical potential of peptide-biomaterial therapeutics.
  • Optimizing biomaterial characteristics is key to harnessing the full potential of HDPs in combating resistant infections.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...